Ligand profile
ZINC34319490
Virtual-screening candidate from ZINC.
Bound to: HT085_RS00335 — tyrosine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC34319490- UniProt (similar protein)
B4RP13- Tanimoto
- 0.688
- Target protein
- HT085_RS00335
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.5
- −1 ≤ LogP ≤ 5 1.50
- MW ≤ 500 Da 231.3
- LogP ≤ 5 1.50
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 83.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
N[C@H](Cc1ccc2cc(O)ccc2c1)C(=O)ON[C@H](Cc1ccc2cc(O)ccc2c1)C(=O)O
InChI=1S/C13H13NO3/c14-12(13(16)17)6-8-1-2-10-7-11(15)4-3-9(10)5-8/h1-5,7,12,15H,6,14H2,(H,16,17)/t12-/m1/s1InChI=1S/C13H13NO3/c14-12(13(16)17)6-8-1-2-10-7-11(15)4-3-9(10)5-8/h1-5,7,12,15H,6,14H2,(H,16,17)/t12-/m1/s1
DDQIHEUTTRSDCH-GFCCVEGCSA-NDDQIHEUTTRSDCH-GFCCVEGCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- TYR
- Homolog
- B4RP13
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC34319490 →
- ZINC ZINC20 ZINC34319490 →
- UniProt UniProt B4RP13 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC34319490”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00335.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 7
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).